Icu Medical — Q3 2025 Earnings Presentation

4 slides from Icu Medical's earnings presentation, Nov 6, 2025

Slide 1: ICU Medical, Inc Q3 2025 Conference Call Presentation
ICU Medical, Inc Q3 2025 Conference Call Presentation November 6, 2025 1
Slide 2: Disclosures
Disclosures > Any statement concerning Management’s expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a rep
Slide 3: 2024-2025 Adjusted Revenue
2024-2025 Adjusted Revenue In $Millions Tracheostomy 2024 2024 2024 2024 2024 2025 2025 2025 Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Vascular Access Consumables 244 262 265 268 1,039 266 273 285 YoY Growth 3% 10% 9% 6% 7% 9% 4% 8% YoY Organic Growth 1 3% 11% 9% 6% 7% 10% 3% 7% Oncology Syringe Systems 157 164 16
Slide 4: 2025 Guidance and Modeling Assumptions
2025 Guidance and Modeling Assumptions In $ Millions, except per share amounts 4